CoChat

Phosphate dysregulation via the XPR1–KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer

Open access
Bondeson, Daniel P., Paolella, Brenton R., Asfaw, Adhana, Rothberg, Michael V., Skipper, Thomas A., Langan, Carly, Mesa, Gabriel, Gonzalez, Alfredo, Surface, Lauren E., Ito, Kentaro, Kazachkova, Mariya, Colgan, William N., Warren, Allison, Dempster, Joshua M., Krill-Burger, John M., Ericsson, Maria, Tang, Andrew A., Fung, Iris, Chambers, Emily S., Abdusamad, Mai, Dumont, Nancy, Doench, John G., Piccioni, Federica, Root, David E., Boehm, Jesse, Hahn, William C., Mannstadt, Michael, McFarland, James M., Vazquez, Francisca, Golub, Todd R. · 2022 · Nature Cancer
Cited by 71

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Despite advances in precision medicine, the clinical prospects for patients with ovarian and uterine cancers have not substantially improved. Here, we analyzed genome-scale CRISPR–Cas9 loss-of-function screens across 851 human cancer cell lines and found that frequent overexpression of SLC34A2—encoding a phosphate importer—is correlated with sensitivity to loss of the phosphate exporter XPR1, both in vitro and in vivo. In patient-derived tumor samples, we observed frequent PAX8-dependent overexpression of SLC34A2, XPR1 copy number amplifications and XPR1 messenger RNA overexpression. Mechanistically, in SLC34A2-high cancer cell lines, genetic or pharmacologic inhibition of XPR1-dependent phosphate efflux leads to the toxic accumulation of intracellular phosphate. Finally, we show that XPR1 requires the novel partner protein KIDINS220 for proper cellular localization and activity, and that disruption of this protein complex results in acidic “vacuolar” structures preceding cell death. These data point to the XPR1–KIDINS220 complex and phosphate dysregulation as a therapeutic vulnerability in ovarian cancer. Golub and colleagues identify the phosphate exporter XPR1 as a therapeutic vulnerability in ovarian and uterine cancers, and show that phosphate efflux inhibition reduces tumor cell viability through accumulation of intracellular phosphate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43018-022-00360-7

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 71

Metadata

Authors
Bondeson, D. P., Paolella, B. R., Asfaw, A., Rothberg, M. V., Skipper, T. A., Langan, C., Mesa, G., Gonzalez, A., Surface, L. E., Ito, K., Kazachkova, M., Colgan, W. N., Warren, A., Dempster, J. M., Krill-Burger, J. M., Ericsson, M., Tang, A. A., Fung, I., Chambers, E. S., Abdusamad, M., Dumont, N., Doench, J. G., Piccioni, F., Root, D. E., Boehm, J., Hahn, W. C., Mannstadt, M., McFarland, J. M., Vazquez, F., & Golub, T. R.
Venue
Nature Cancer
Published
2022-04-18
Volume
3
Issue
6
Pages
681-695
ISSN
2662-1347 (ISSN-L)
OpenAlex
W4225977695
Cited by
71
References
20
FWCI
10.84
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phosphate dysregulation via the XPR1–KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer. https://app.cochat.ai/papers/10.1038/s43018-022-00360-7
The paper
Bondeson, D. P., Paolella, B. R., Asfaw, A., Rothberg, M. V., Skipper, T. A., Langan, C., Mesa, G., Gonzalez, A., Surface, L. E., Ito, K., Kazachkova, M., Colgan, W. N., Warren, A., Dempster, J. M., Krill-Burger, J. M., Ericsson, M., Tang, A. A., Fung, I., Chambers, E. S., . . . Golub, T. R. (2022). Phosphate dysregulation via the XPR1–KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer. Nature Cancer. https://doi.org/10.1038/s43018-022-00360-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.